Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Prime Medicine Inc’s current trading price is -84.04% away from its 52-week high, while its distance from the 52-week low is 18.39%. The stock’s price range over this period has fluctuated between $1.12 and $8.27. The company, operating within the financial sector, had a trading volume of approximately 2.29 million for the day, which was noticeably higher than the average daily share volume of 1.46 million over the last 3 months.
Prime Medicine Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $8.27 on 05/21/24, while the lowest price for the same duration was marked at $1.12 on 04/09/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Prime Medicine Inc (PRME) has experienced a quarterly decline of -47.62% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 173.13M and boasts a workforce of 214 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.3054, with a change in price of -1.8400. Similarly, Prime Medicine Inc recorded 1,307,469 in trading volume during the last 100 days, posting a change of -58.23%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for PRME stands at 0.27. Similarly, the long-term debt-to-equity ratio is also 0.24.
PRME Stock Stochastic Average
Today, Prime Medicine Inc’s raw stochastic average for the past 50 days stands at 13.11%, indicating a decline from the raw stochastic average of the last 20 days, which was 26.03%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 31.94% and 43.61% respectively.
PRME Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -54.79%.However, over the last six months, we can see a stronger performance of -66.67%. Over the last 30 days, the price of PRME has fallen by 14.78%. And in the last five days, it has fallen by -24.14%.
